Risk Factors for Patient-Important Upper Gastrointestinal Bleeding

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Patient-important gastrointestinal bleeding is a critical outcome for invasively ventilated patients.
• Risk factors for this specific bleeding event remain largely unknown.
• Understanding these factors is crucial for developing targeted prevention strategies.

Purpose of the Study:

• To identify and analyze risk factors associated with patient-important upper gastrointestinal bleeding in adults requiring invasive ventilation.
• To provide data for improving patient safety and clinical decision-making in intensive care units.

Main Methods:

• A pre-planned regression analysis was conducted on an international trial database.
• Evaluated both baseline and time-varying risk factors within the preceding 3 days.
• Accounted for illness severity (APACHE II score) and the competing risk of mortality.

Main Results:

• Patient-important upper gastrointestinal bleeding occurred in 2.7% of 4,821 patients.
• Increased risk was linked to higher APACHE II scores, vasopressor use, severe thrombocytopenia, and platelet inhibitors.
• Pantoprazole use (HR 0.36) and enteral nutrition (HR 0.81 per 500 mL/day) were associated with significantly lower bleeding risk.

Conclusions:

• Several factors significantly influence the risk of patient-important upper gastrointestinal bleeding during invasive ventilation.
• Pantoprazole demonstrated a protective effect independent of enteral nutrition volume.
• Enteral nutrition also showed a protective association with bleeding risk.